Literature DB >> 33300499

Functional significance of germline EPAS1 variants.

Trisha Dwight1,2, Edward Kim1,2, Karine Bastard1,2, Diana E Benn1,2, Graeme Eisenhofer3,4, Susan Richter3, Massimo Mannelli5, Elena Rapizzi5, Aleksander Prejbisz6, Mariola Pęczkowska6, Karel Pacak7, Roderick Clifton-Bligh1,2,8.   

Abstract

Mosaic or somatic EPAS1 mutations are associated with a range of phenotypes including pheochromocytoma and/or paraganglioma (PPGL), polycythemia and somatostatinoma. The pathogenic potential of germline EPAS1 variants however is not well understood. We report a number of germline EPAS1 variants occurring in patients with PPGL, including a novel variant c.739C>A (p.Arg247Ser); a previously described variant c.1121T>A (p.Phe374Tyr); several rare variants, c.581A>G (p.His194Arg), c.2353C>A (p.Pro785Thr) and c.2365A>G (p.Ile789Val); a common variant c.2296A>C (p.Thr766Pro). We performed detailed functional studies to understand their pathogenic role in PPGL. In transient transfection studies, EPAS1/HIF-2α p.Arg247Ser, p.Phe374Tyr and p.Pro785Thr were all stable in normoxia. In co-immunoprecipitation assays, only the novel variant p.Arg247Ser showed diminished interaction with pVHL. A direct interaction between HIF-2α Arg247 and pVHL was confirmed in structural models. Transactivation was assessed by means of a HRE-containing reporter gene in transiently transfected cells, and significantly higher reporter activity was only observed with EPAS1/HIF-2α p.Phe374Tyr and p.Pro785Thr. In conclusion, three germline EPAS1 variants (c.739C>A (p.Arg247Ser), c.1121T>A (p.Phe374Tyr) and c.2353C>A (p.Pro785Thr)) all have some functional features in common with somatic activating mutations. Our findings suggest that these three germline variants are hypermorphic alleles that may act as modifiers to the expression of PPGLs.

Entities:  

Keywords:  EPAS1; HIF-2α; VHL; hypoxia- inducible factors; paraganglioma; pheochromocytoma

Mesh:

Substances:

Year:  2021        PMID: 33300499      PMCID: PMC7989857          DOI: 10.1530/ERC-20-0280

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  51 in total

1.  SIFT missense predictions for genomes.

Authors:  Robert Vaser; Swarnaseetha Adusumalli; Sim Ngak Leng; Mile Sikic; Pauline C Ng
Journal:  Nat Protoc       Date:  2015-12-03       Impact factor: 13.491

2.  The ClusPro web server for protein-protein docking.

Authors:  Dima Kozakov; David R Hall; Bing Xia; Kathryn A Porter; Dzmitry Padhorny; Christine Yueh; Dmitri Beglov; Sandor Vajda
Journal:  Nat Protoc       Date:  2017-01-12       Impact factor: 13.491

3.  Pathways for Oxygen Regulation and Homeostasis: The 2016 Albert Lasker Basic Medical Research Award.

Authors:  William G Kaelin; Peter J Ratcliffe; Gregg L Semenza
Journal:  JAMA       Date:  2016-09-27       Impact factor: 56.272

4.  RACK1 competes with HSP90 for binding to HIF-1alpha and is required for O(2)-independent and HSP90 inhibitor-induced degradation of HIF-1alpha.

Authors:  Ye V Liu; Jin H Baek; Huafeng Zhang; Roberto Diez; Robert N Cole; Gregg L Semenza
Journal:  Mol Cell       Date:  2007-01-26       Impact factor: 17.970

Review 5.  A new twist in neuroendocrine tumor research: Pacak-Zhuang syndrome, HIF-2α as the major player in its pathogenesis and future therapeutic options.

Authors:  Ivana Jochmanova; Ivica Lazurova
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2014-04-29       Impact factor: 1.245

6.  Mutations of the VHL gene in sporadic renal cell carcinoma: definition of a risk factor for VHL patients to develop an RCC.

Authors:  C Gallou; D Joly; A Méjean; F Staroz; N Martin; G Tarlet; M T Orfanelli; R Bouvier; D Droz; Y Chrétien; J M Maréchal; S Richard; C Junien; C Béroud
Journal:  Hum Mutat       Date:  1999       Impact factor: 4.878

Review 7.  Role of hypoxia in the hallmarks of human cancer.

Authors:  Kai Ruan; Gang Song; Gaoliang Ouyang
Journal:  J Cell Biochem       Date:  2009-08-15       Impact factor: 4.429

8.  Artificial ligand binding within the HIF2alpha PAS-B domain of the HIF2 transcription factor.

Authors:  Thomas H Scheuermann; Diana R Tomchick; Mischa Machius; Yan Guo; Richard K Bruick; Kevin H Gardner
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-07       Impact factor: 11.205

Review 9.  PHD2: from hypoxia regulation to disease progression.

Authors:  Ana M Meneses; Ben Wielockx
Journal:  Hypoxia (Auckl)       Date:  2016-04-11

10.  The mutational constraint spectrum quantified from variation in 141,456 humans.

Authors:  Konrad J Karczewski; Laurent C Francioli; Grace Tiao; Beryl B Cummings; Jessica Alföldi; Qingbo Wang; Ryan L Collins; Kristen M Laricchia; Andrea Ganna; Daniel P Birnbaum; Laura D Gauthier; Harrison Brand; Matthew Solomonson; Nicholas A Watts; Daniel Rhodes; Moriel Singer-Berk; Eleina M England; Eleanor G Seaby; Jack A Kosmicki; Raymond K Walters; Katherine Tashman; Yossi Farjoun; Eric Banks; Timothy Poterba; Arcturus Wang; Cotton Seed; Nicola Whiffin; Jessica X Chong; Kaitlin E Samocha; Emma Pierce-Hoffman; Zachary Zappala; Anne H O'Donnell-Luria; Eric Vallabh Minikel; Ben Weisburd; Monkol Lek; James S Ware; Christopher Vittal; Irina M Armean; Louis Bergelson; Kristian Cibulskis; Kristen M Connolly; Miguel Covarrubias; Stacey Donnelly; Steven Ferriera; Stacey Gabriel; Jeff Gentry; Namrata Gupta; Thibault Jeandet; Diane Kaplan; Christopher Llanwarne; Ruchi Munshi; Sam Novod; Nikelle Petrillo; David Roazen; Valentin Ruano-Rubio; Andrea Saltzman; Molly Schleicher; Jose Soto; Kathleen Tibbetts; Charlotte Tolonen; Gordon Wade; Michael E Talkowski; Benjamin M Neale; Mark J Daly; Daniel G MacArthur
Journal:  Nature       Date:  2020-05-27       Impact factor: 69.504

View more
  1 in total

1.  Hypoxia-inducible factor underlies von Hippel-Lindau disease stigmata.

Authors:  Michael Ohh; Cassandra C Taber; Fraser G Ferens; Daniel Tarade
Journal:  Elife       Date:  2022-08-30       Impact factor: 8.713

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.